Cipla: South Africa's Cipla Medpro shareholders approve $512 mn buyout
Drug major Cipla today said shareholders of South Africa-based Cipla Medpro has approved its around USD 512 million buyout offer.
Cipla in a filing to the BSE said: "The result of the general meeting of Medpro shareholders has been disclosed by Medpro to the Stock Exchange News Service of the JSE Limited and the scheme has received the requisite approvals from the shareholders of Medpro."
Earlier this year, Cipla had offered to pay 10 rand per share to acquire 100 per cent of Cipla Medpro for a consideration of around USD 512 million.
Cipla supplies majority of Cipla Medpro's drugs through a long-standing agreement but has never owned a stake in it.
The acquisition of South African firm would help Cipla further strengthen its position in the African continent.
Shares of Cipla today closed at Rs 411.45 apiece on the BSE, up 3.25 per cent from their previous close.